National Renewable Energy Laboratory

The National Renewable Energy Laboratory (NREL), located in Golden, Colorado, is the United States' primary laboratory for renewable energy and energy efficiency research and development. The National Renewable Energy Laboratory (NREL) is a government-owned, contractor-operated facility; it is funded through the U.S. Department of Energy (DOE). This arrangement allows a private entity to operate the lab on behalf of the federal government under a prime contract. NREL receives funding from Congress to be applied toward research and development projects. NREL also performs research on photovoltaics (PV) under the National Center for Photovoltaics. NREL has a number of PV research capabilities including research and development, testing, and deployment. NREL's campus houses several facilities dedicated to PV research. Established in 1974, NREL began operating in 1977 as the Solar Energy Research Institute. Under the Jimmy Carter administration, it was the recipient of a large budget and its activities went beyond research and development in solar energy as it tried to popularize knowledge about already existing technologies, like passive solar, amongst the population.

Website
http://www.nrel.gov/
Wikipedia
http://en.wikipedia.org/wiki/National_Renewable_Energy_Laboratory
Some content from Wikipedia, licensed under CC BY-SA

Materials Science

'Harvesting' microparticles from a liquid jet

Microspheres, microlenses and microfibers can now be produced by irradiating a fluid jet with ultraviolet light. The result is that locally, a polymer of a desired shape is formed. This process, called in-air photopolymerization, ...

General Physics

Detecting solar neutrinos with the Borexino experiment

Neutrinos are chargeless particles with about a mass about a millionth that of an electron that are created by the nuclear processes that occur in the Sun and other stars. These particles are often colorfully described as ...

Diseases, Conditions, Syndromes

How safe are the new COVID-19 vaccines?

(HealthDay)—Two COVID-19 vaccines are on the verge of approval in the United States, with pharmaceutical companies promising that millions of doses will be available to the first wave of recipients within a matter of weeks.

Medications

Antiviral drugs have no effect on mortality in COVID-19

(HealthDay)—For hospitalized patients with COVID-19, remdesivir, hydroxychloroquine, lopinavir, and interferon regimens seem to have little to no effect on mortality, according to a study published online Dec. 2 in the ...

Diseases, Conditions, Syndromes

COVID-19 pandemic responsible for decrease in hepatitis C testing

New research from Boston Medical Center finds that the COVID-19 emergency systemic changes made to decrease in-person visits during the pandemic have led to a decrease in hospital-wide Hepatitis C (HCV) testing by 50 percent, ...

page 2 from 6